156 related articles for article (PubMed ID: 6407845)
1. Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine.
Bartholeyns J
Eur J Cancer Clin Oncol; 1983 Apr; 19(4):567-72. PubMed ID: 6407845
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.
Fozard JR; Part ML; Prakash NJ; Grove J
Eur J Pharmacol; 1980 Aug; 65(4):379-91. PubMed ID: 6773783
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
[TBL] [Abstract][Full Text] [Related]
5. Effects of DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene.
Fozard JR; Prakash NJ
Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):72-7. PubMed ID: 6811956
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
7. Indirect evidence for a strict negative control of S-adenosyl-L-methionine decarboxylase by spermidine in rat hepatoma cells.
Mamont PS; Joder-Ohlenbusch AM; Nussli M; Grove J
Biochem J; 1981 May; 196(2):411-22. PubMed ID: 6797404
[TBL] [Abstract][Full Text] [Related]
8. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Dunzendorfer U; Knöner M
Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811
[TBL] [Abstract][Full Text] [Related]
9. The role of polyamine depletion and accumulation of decarboxylated S-adenosylmethionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine.
Pegg AE
Biochem J; 1984 Nov; 224(1):29-38. PubMed ID: 6439194
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
Takigawa M; Verma AK; Simsiman RC; Boutwell RK
Cancer Res; 1983 Aug; 43(8):3732-8. PubMed ID: 6407752
[TBL] [Abstract][Full Text] [Related]
11. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
Claverie N; Mamont PS
Cancer Res; 1989 Aug; 49(16):4466-71. PubMed ID: 2501026
[TBL] [Abstract][Full Text] [Related]
12. Polyamine biosynthesis in trichomonads.
North MJ; Lockwood BC; Bremner AF; Coombs GH
Mol Biochem Parasitol; 1986 Jun; 19(3):241-9. PubMed ID: 3090433
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the growth inhibitory effect of alpha-difluoromethylornithine by putrescine but not by other divalent cations.
Oredsson SM; Anehus S; Heby O
Mol Cell Biochem; 1984 Sep; 64(2):163-72. PubMed ID: 6438490
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of DL-alpha-difluoromethylornithine on the polyamine and nucleotide phosphate metabolism in P388/S leukemia cells.
Kremmer T; Boldizsár M; Holczinger L
Exp Cell Biol; 1986; 54(1):8-15. PubMed ID: 3082689
[TBL] [Abstract][Full Text] [Related]
15. Polyamines regulate human medullary thyroid carcinoma TT-cell proliferation and secretion of calcitonin and calcitonin gene-related peptide.
Sjöholm A; Bucht E; Theodorsson E; Larsson R; Nygren P
Mol Cell Endocrinol; 1994 Jul; 103(1-2):89-94. PubMed ID: 7958401
[TBL] [Abstract][Full Text] [Related]
16. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
17. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine.
Mamont PS; Danzin C; Kolb M; Gerhart F; Bey P; Sjoerdsma A
Biochem Pharmacol; 1986 Jan; 35(2):159-65. PubMed ID: 3080004
[TBL] [Abstract][Full Text] [Related]
18. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D
J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
20. Polyamines and the development of monocrotaline-induced pulmonary hypertension.
Olson JW; Hacker AD; Altiere RJ; Gillespie MN
Am J Physiol; 1984 Oct; 247(4 Pt 2):H682-5. PubMed ID: 6437245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
